SCHEMBL2321992

SCHEMBL2321992

Cc1ccc(-c2ccc(NC=O)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.50
KIF11 P52732 1/20 0.48
LMNA P02545 2/20 0.46
MAPT P10636 4/20 0.44
NPC1 O15118 4/20 0.44
RAB9A P51151 3/20 0.44
ALOX12 P18054 1/20 0.44
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
CYP2A6 P11509 1/20 0.41
DHODH Q02127 1/20 0.41
TDP1 Q9NUW8 1/20 0.40
KDM4E B2RXH2 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TGM2 P21980 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
POLB P06746 1/20 0.39
HPGD P15428 1/20 0.38
ATM Q13315 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL428217 0.93 ALDH1A1 (0.56) ALDH1A1LMNAMAPTNPC1RAB9A
SCHEMBL10889869 0.91 ALDH1A1 (0.54) ALDH1A1LMNAMAPTNPC1RAB9A
SCHEMBL14403087 0.81 ALDH1A1 (0.45) ALDH1A1LMNAMAPTNPC1RAB9A
SCHEMBL14402927 0.81 TEAD4 (0.47) ALDH1A1LMNAMAPTNPC1RAB9A
SCHEMBL469386 0.80 ALDH1A1 (0.72) ALDH1A1LMNAMAPTNPC1RAB9A
SCHEMBL14418354 0.79 ALDH1A1 (0.73) ALDH1A1LMNAMAPTNPC1RAB9A
SCHEMBL223423 0.79 ALDH1A1 (0.73) ALDH1A1LMNAMAPTNPC1RAB9A
SCHEMBL14471636 0.78 ALDH1A1 (0.42) ALDH1A1LMNAPOLBLIMK1
SCHEMBL2322134 0.78 AURKA (0.50) KIF11LMNAMAPTMEN1KMT2A
SCHEMBL2322247 0.77 ALDH1A1 (0.50) ALDH1A1KIF11LMNAMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2999699-B1 PURINE DIONES AS WNT PATHWAY MODULATORS AGENCY SCIENCE TECH & RES (SG) 2020-04-29 EP disclosed
US-9079899-B2 Anti-staphylococcal celecoxib derivatives THE OHIO STATE UNIVERSITY (US) 2015-07-14 US disclosed
US-20130289004-A1 ANTI-STAPHYLOCOCCAL CELECOXIB DERIVATIVES THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2013-10-31 US disclosed
WO-2011094890-A1 PHENYLALANINE DERIVATIVES AND THEIR USE AS NON-PEPTIDE GLP-1 RECEPTOR MODULATORS ARGUSINA INC. (US) 2011-08-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130289004-A1 ANTI-STAPHYLOCOCCAL CELECOXIB DERIVATIVES PTGS1, IL17A, IKBKE ALDH1A1 2417/4885KIF11 3527/4885LMNA 3471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.